Abstract
Neurotoxicology is hampered by the inability to predict regional and cellular targets of toxicant-induced damage. Evaluating astrogliosis overcomes this problem because reactive astrocytes highlight the location of toxicant-induced damage. While enhanced expression of glial fibrillary acidic protein is a hallmark of astrogliosis, few other biomarkers have been identified. However, bacterial artificial chromosome - translating ribosome affinity purification (bacTRAP) technology allows for characterization of the actively translating transcriptome of a particular cell type; use of this technology in aldehyde dehydrogenase 1 family member L1 (ALDH1L1) bacTRAP mice can identify genes selectively expressed in astrocytes. The aim of this study was to characterize additional biomarkers of neurotoxicity-induced astrogliosis using ALDH1L1 bacTRAP mice. The known dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 12.5 mg/kg s.c.) was used to induce astrogliosis. Striatal tissue was obtained 12, 24, and 48 h following exposure for the isolation of actively translating RNA. Subsequently, MPTP-induced changes in this RNA pool were analyzed by microarray and 184 statistically significant, differentially expressed genes were identified. The dataset was interrogated by gene ontology, pathway, and co-expression network analyses, which identified novel genes, as well as those with known immune and inflammatory functions. Using these analyses, we were directed to several genes associated with reactive astrocytes. Of these, TIMP1 and miR-147 were identified as candidate biomarkers because of their robust increased expression following both MPTP and trimethyl tin exposures. Thus, we have demonstrated that bacTRAP can be used to identify new biomarkers of astrogliosis and aid in the characterization of astrocyte phenotypes induced by toxicant exposures. Open Science Badges: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. (Figure presented.). Cover Image for this issue: doi: 10.1111/jnc.14518.
Original language | English |
---|---|
Pages (from-to) | 420-440 |
Number of pages | 21 |
Journal | Journal of Neurochemistry |
Volume | 150 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry
Funding
We appreciate the excellent technical assistance provided by Ali A. Yilmaz, Brenda K. Billig, Christopher M. Felton, and Fang Ma. The authors declare no conflicts of interest. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. This work was supported by the Assistant Secretary of Defense for Health Affairs, through the Gulf War Illness Research Program. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was supported by Intramural funds from the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health and Department of Defense and Congressionally Directed Medical Research Program: Gulf War Illness awards (GW120037 and GW120045). All experiments were conducted in compliance with the ARRIVE guidelines. We appreciate the excellent technical assistance provided by Ali A. Yilmaz, Brenda K. Billig, Christopher M. Felton, and Fang Ma. The authors declare no conflicts of interest. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. This work was supported by the Assistant Secretary of Defense for Health Affairs, through the Gulf War Illness Research Program. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was supported by Intramural funds from the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health and Department of Defense and Congressionally Directed Medical Research Program: Gulf War Illness awards (GW120037 and GW120045).
Funders | Funder number |
---|---|
Assistant Secretary of Defense for Health Affairs | |
National Institute for Occupational Safety and Health and Department of Defense | |
U.S. Department of Defense | |
Centers for Disease Control and Prevention | |
Congressionally Directed Medical Research Programs | GW120037, GW120045 |
National Institute for Occupational Safety and Health |
Keywords
- Astrocyte
- astrogliosis
- biomarker
- neurotoxicity
- transcriptome
- translating RNA